¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
9/9 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2023-09-07
Á¶È¸¼ö
146


¾È³çÇϼ¼¿ä ¿äÇÑÀÔ´Ï´Ù.

À̹ø ÁÖ ¹ßÇ¥ ³í¹®Àº 2020³âµµ Autophagy¿¡ ÃâÆÇµÈ 'Autophagic protein ATG5 controls antiviral immunity via glycolytic reprogramming of dendritic cells against respiratory syncytial virus infection'ÀÔ´Ï´Ù.

ÁøÇÙ»ý¹°¿¡¼­ Macroautophagy/autophagy´Â cytoplasmic substrates µîÀ» ¼ö¼ÛÇÏ¿© lysosomeÀ¸·Î ¼ö¼ÛÇÏ¿© autolysosomeÀ» Çü¼ºÇÏ°í, ÀÌ·¯ÇÑ substrate µîÀ» lysosomal degradationÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ autophagy´Â RSV infection »óȲ¿¡¼­ ¹ßÇöÀÌ Áõ°¡Çϸç, ÀÌ´Â RSVÀÇ replication¿¡ °ü¿©ÇÑ´Ù°í ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. 

ÀÌ¿¡ º» ¿¬±¸ÆÀÀº dendritic cellÀÌ RSV¿¡ °¨¿°µÈ »óȲ¿¡¼­ autophagy related proteinÀÎ ATG5ÀÇ ¿ªÇÒÀ» ±Ô¸íÇÏ°í atg5ÀÇ deletionÀ¸·Î ÀÎÇÑ metabolic reprogramming¿¡ ´ëÇؼ­µµ ¹àÈ÷°íÀÚ ÇÏ¿´½À´Ï´Ù.

¿ì¼± dendritic cell specific atg5 deletion systemÀ» »ç¿ëÇÏ¿© CD8 T cell response¿Í IL6, IFNb µîÀÇ proinflammatory cytokineÀÌ Áõ°¡ÇÑ´Ù´Â °ÍÀ» ¹àÇû½À´Ï´Ù.

ÀÌÈÄ RNA sequencing, transcriptome analysis¸¦ »ç¿ëÇÏ¿© atg5°¡ deletionµÈ dendritic cell¿¡¼­ metabolic reprogrammingÀ» È®ÀÎÇÏ¿´°í, ÀÌ·¯ÇÑ metabolic reprogramming Áß glycolysis¿¡ ÁýÁßÇÏ¿´½À´Ï´Ù.

±× °á°ú·Î atg5°¡ deletionµÈ dendritic cellÀº ´õ ³ôÀº glycolysis¿Í glycolytic capacity¸¦ °¡ÁüÀÌ È®ÀεǾúÀ¸¸ç ÀÌ´Â mTOR complex 1ÀÇ signaling pathway¸¦ ÅëÇØ »óÇâ Á¶ÀýµÈ´Ù´Â °ÍÀ» ¹àÇû½À´Ï´Ù.

¶ÇÇÑ in vivo ½ÇÇèÀ» ÅëÇØ atg5ÀÇ deletionÀÌ CD11b positiveÇÑ dendritic cell°ú CD103 postiveÇÑ dendritic cell ¸ðµÎ¿¡¼­ MHC class I ºÐÀÚÀÇ ¹ßÇöÀÌ Áõ°¡ÇÏ´Â °ÍÀ» È®ÀÎÇÏ¿´À¸¸ç ÀÌ´Â Áõ°¡ÇÑ Glycolysis¿¡ ÀÇÇÑ °ÍÀÓÀ» ¹àÇû½À´Ï´Ù.

°á°úÀûÀ¸·Î º» ¿¬±¸ÆÀÀº RSV infection »óȲ¿¡¼­ ATG5°¡ immunometabolic regulator·Î¼­ ÀÛ¿ëÇÑ´Ù´Â °ÍÀ» ¹àÇûÀ¸¸ç, ÀÌ´Â RSV infection¿¡ ´ëÀÀÇÏ´Â »õ·Î¿î Ä¡·á¹æ¹ý¿¡ ±â¿©ÇÒ ¼ö ÀÖÀ» °ÍÀ̶ó°í ½Ã»çÇÏ°í ÀÖ½À´Ï´Ù.

À§ ³í¹®À» °øºÎÇÑ ÀÌÀ¯´Â, ÃÖ±Ù º¸°Çº¹ÁöºÎ °úÁ¦¸¦ ÅëÇØ RSV infection¿¡ ´ëÇؼ­ ÀÚÁÖ Á¢ÇÏ°Ô µÇ¾ú´Âµ¥, ÀÌ·¯ÇÑ RSV infection »óȲ¿¡ °ü¿©ÇÏ´Â autophagyÀÇ ¿ªÇÒ°ú ÀÌ·¯ÇÑ »óȲ¿¡¼­ innate immune cellÀÎ dendritic cellÀÇ metabolic reprogramming¿¡ ´ëÇؼ­ °øºÎÇϱâ À§ÇØ ¼±Á¤ÇÏ°Ô µÇ¾ú½À´Ï´Ù.

³í¹® ¸µÅ©: https://www.tandfonline.com/doi/full/10.1080/15548627.2020.1812218
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
9/16 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ´ÙÁ¤ÀÔ´Ï´Ù. Á¦°¡ À̹ø¿¡ ¼±Á¤ÇÑ ³í¹®Àº2023³â Cell metabolism¿¡ ÃâÆÇµÈ 'Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity'ÀÔ´Ï´Ù. À§ ³í¹®Àº PUFA Áß¿¡¼­ linoleic acid°¡ CTLÈ°¼ºÀ» Çâ»ó½ÃÄÑ tumor controlÀ» ÀÌ·ç¾î ³¿¿¡ ÀÖ¾î positive..
ÀÌÀü±Û
9/9 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº ¿ÃÇØ Science advances ¿¡ ÃâÆÇµÈ "A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus" ÀÔ´Ï´Ù. COVID 19 ¿Í µ¶°¨ ¹ÙÀÌ·¯½º°¡ ÇÔ²² °¨¿°µÉ ½Ã ´õ ³ôÀº »ç¸Á·ü°ú SARS-CoV-2 °¨¿°¼ºÀÌ ÃË..